Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4.
Madsen, H
Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4. [electronic resource] - Clinical pharmacology and therapeutics Mar 1997 - 319-24 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-9236
10.1016/S0009-9236(97)90164-8 doi
Adult
Antidepressive Agents, Tricyclic--pharmacokinetics
Aryl Hydrocarbon Hydroxylases
Cytochrome P-450 CYP1A2--physiology
Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System--physiology
Female
Humans
Imipramine--pharmacokinetics
Male
Methylation
Mixed Function Oxygenases--physiology
Phenotype
Regression Analysis
Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4. [electronic resource] - Clinical pharmacology and therapeutics Mar 1997 - 319-24 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-9236
10.1016/S0009-9236(97)90164-8 doi
Adult
Antidepressive Agents, Tricyclic--pharmacokinetics
Aryl Hydrocarbon Hydroxylases
Cytochrome P-450 CYP1A2--physiology
Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System--physiology
Female
Humans
Imipramine--pharmacokinetics
Male
Methylation
Mixed Function Oxygenases--physiology
Phenotype
Regression Analysis